Nektar Therapeutics (BMV:NKTR)

Nektar Therapeutics Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	21,059	3,575	1,822	8,286	51,115	60,686
Market Cap Growth	448.80%	96.17%	-78.01%	-83.79%	-15.77%	-15.27%
Enterprise Value	19,182	2,680	-338	3,485	38,260	42,121
Last Close Price	1030.00	270.00	766.65	4653.90	4653.90	6186.60
PS Ratio	18.34	1.74	1.20	4.61	24.47	19.94
PB Ratio	13.49	2.82	0.82	1.16	3.67	2.83
P/TBV Ratio	13.49	2.82	0.82	1.46	4.14	3.05
EV/Sales Ratio	16.84	1.31	-	1.94	18.31	13.84
EV/FCF Ratio	-5.49	-	-	-	-	-
Debt / Equity Ratio	1.96	3.20	1.76	0.78	0.50	0.33
Asset Turnover	0.21	0.28	0.16	0.10	0.08	0.09
Inventory Turnover	-	-	1.91	1.24	1.60	1.39
Quick Ratio	4.09	4.18	5.97	7.53	8.90	9.55
Current Ratio	4.24	4.26	6.45	8.01	9.34	9.83
Return on Equity (ROE)	-180.24%	-124.10%	-110.95%	-70.39%	-59.64%	-35.80%
Return on Assets (ROA)	-27.98%	-23.14%	-15.25%	-16.43%	-21.00%	-13.51%
Return on Capital (ROIC)	-33.61%	-26.34%	-16.66%	-17.96%	-22.80%	-14.33%
Return on Capital Employed (ROCE)	-58.00%	-53.60%	-39.00%	-37.40%	-43.20%	-26.70%
Earnings Yield	-10.52%	-69.35%	-256.12%	-86.68%	-21.01%	-14.57%
FCF Yield	-16.58%	-103.28%	-179.50%	-72.91%	-17.15%	-10.51%
Buyback Yield / Dilution	-14.07%	-8.24%	-1.53%	-2.10%	-2.64%	-2.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.